Luminex

Traded on the St. Petersburg Stock Exchange
Luminex Corporation is a biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences. The company's headquarters are in Austin, Texas, USA.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Luminex balance sheet

Report period2016 2017 2018 2019 2020 Q1 21
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Luminex cash flows

Report period2016 2017 2018 2019 2020 Q1 21 TTM
End date of the reporting period
Sales
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Luminex multipliers

Report period2016 2017 2018 2019 2020 Q1 21 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Luminex profitability

Report period2016 2017 2018 2019 2020 Q1 21 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Luminex assets
Luminex cash flows
Luminex news
20.05.2021
The Luminex Board of Directors announced a quarterly dividend of $0.1 per share. The last day to buy securities to receive the dividend is June 15, 2021. The annual dividend yield may reach 1.36%.
Source: {source} pictogram investor.luminexcorp.com
Pictogram next
12.04.2021
The board of directors of Italian DiaSorin has approved a merger agreement with Luminex. DiaSorin will pay Luminex shareholders $37 per share, which equals the company's total value of $1.8 billion. The deal is expected to close in Q3 2021.
Source: {source} pictogram luminexcorp.com
Pictogram next
09.02.2021
Net income of Luminex under GAAP for 2020 was $15.17 million, compared to a loss of $3.838 million in the previous year. Revenue increased 24.7% to $417.396 million from $334.638 million a year earlier.
Source: {source} pictogram investor.luminexcorp.com
Pictogram next
08.02.2021
The Luminex Board of Directors announced a quarterly dividend of $0.1 per share. The last day to buy securities to receive the dividend is March 23, 2021. The annual dividend yield may reach 1.32%.
Source: {source} pictogram investor.luminexcorp.com
Pictogram next
All Luminex news
General information
Company nameLuminex
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services
Business address12212 TECHNOLOGY BLVD 512-219-8020 AUSTIN TX 78727 5122494741
Mailing address12212 TECHNOLOGY BLVD AUSTIN TX 78727
Websiteinvestor.luminexcorp.com
Information disclosurewww.sec.gov